moxifloxacin has been researched along with Biliary Tract Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Encke, J; Gutt, C; Hoppe-Tichy, T; Köninger, J; Ober, MC; Schunter, O; Sonntag, HG; Swoboda, S; Weigand, MA | 1 |
| Brown, DB; Eschelman, DJ; Gonsalves, CF; Khan, W; McCann, JW; Sato, T; Sullivan, KL | 1 |
2 other study(ies) available for moxifloxacin and Biliary Tract Diseases
| Article | Year |
|---|---|
Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Biliary Tract Diseases; Cholecystitis; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Gallbladder; Humans; Infusions, Intravenous; Male; Middle Aged; Moxifloxacin; Quinolines; Serum; Time Factors; Young Adult | 2009 |
Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Aza Compounds; Biliary Tract Diseases; Case-Control Studies; Chemoembolization, Therapeutic; Embolization, Therapeutic; Ethiodized Oil; Female; Fluoroquinolones; Humans; Liver Abscess; Liver Neoplasms; Male; Moxifloxacin; Pilot Projects; Quinolines; Radiography, Interventional; Retrospective Studies; Risk Factors | 2011 |